银屑病中慢性应激相关神经活动与亚临床心血管病的关联:一项前瞻性队列研究
研究纳入164例银屑病患者和47名健康志愿者,用18-氟脱氧葡萄糖PET/CT评估杏仁核活动、造血系统活动和主动脉血管炎症,用冠状动脉CTA量化非钙化斑块负荷;银屑病患者杏仁核活动高于志愿者,且与骨髓活动和亚临床心血管病指标相关;30例重度患者治疗1年后皮肤改善伴杏仁核活动、骨髓活动和血管炎症下降,非钙化斑块负荷无进展。
要点
- 银屑病患者杏仁核活动较健康志愿者升高,且与骨髓活动及亚临床心血管病指标相关。
- 杏仁核活动与心血管病的关联部分由造血系统活动介导(血管炎症20.9%、非钙化斑块负荷36.7%)。
- 重度银屑病治疗1年后皮肤改善伴随杏仁核活动、骨髓活动和血管炎症下降,非钙化斑块负荷无进展。
核心结论
- 在银屑病这一慢性炎症性疾病状态中,作为慢性应激表现的杏仁核活动对亚临床心血管病风险有实质性贡献。
研究设计与样本
- 前瞻性队列研究,纳入164例连续银屑病患者和47名健康志愿者,行18-氟脱氧葡萄糖PET/CT评估杏仁核活动、造血系统活动和血管炎症,行冠状动脉CTA量化非钙化斑块负荷;另对30例连续的重度银屑病患者(银屑病面积严重指数评分>10)随访1年。
关键影像表现/征象
- 银屑病患者杏仁核活动高于健康志愿者。
- 杏仁核活动与骨髓活动相关(β=0.20,p=0.01)。
- 杏仁核活动与血管炎症相关(β=0.31,p<0.001),与非钙化斑块负荷相关(β=0.27,p<0.001)。
- 重度银屑病患者治疗1年后皮肤病变改善,伴随杏仁核活动、骨髓活动和血管炎症下降,非钙化斑块负荷无进展。
诊断标准与关键数值
- 银屑病队列为中青年(平均年龄50岁),心血管风险低(Framingham风险评分中位数3),银屑病活动度为轻至中度(银屑病面积严重指数评分中位数5.6)。
- 重度银屑病定义为银屑病面积严重指数评分>10。
- 杏仁核活动与心血管病的关联部分由造血系统活动介导:血管炎症中介比例20.9%,非钙化斑块负荷中介比例36.7%。
局限性
- 需要采用应激的心理测量方法开展进一步研究以探索治疗影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study hypothesized that there is an association between chronic stress (as indexed by resting amygdalar activity [AmygA]), hematopoietic system activity (HMPA), and subclinical cardiovascular indexes (aortic vascular inflammation [VI] and noncalcified coronary plaque burden [NCB]) in psoriasis (PSO). The study also hypothesized that treatment of PSO would improve these parameters.
BACKGROUND: PSO is a stress-related chronic inflammatory condition that is associated with increased prevalence of subclinical cardiovascular disease (CVD). In individuals without PSO, stress has been linked to CVD through a serial biological pathway that involves the amygdala, hematopoietic tissues, and atherosclerotic plaques.
METHODS: A total of 164 consecutive patients with PSO and 47 healthy volunteers underwent 18-fluorodeoxyglucose positron emission tomography/computed tomography scans for assessment of AmygA, HMPA, and VI, as well as coronary computed tomography angiography scans for quantifying NCB. Furthermore, a consecutive subset of 30 patients with severe PSO (Psoriasis Area Severity Index Score >10) were followed at 1 year to assess the relationship between skin disease improvement and AmygA, HMPA, VI, and NCB.
RESULTS: The PSO cohort was middle-aged (mean age: 50 years), had low cardiovascular risk (Framingham risk score: median: 3) and had mild to moderate PSO activity (median Psoriasis Area Severity Index Score: 5.6). AmygA was higher in patients with PSO compared to volunteer participants. AmygA was associated with HMPA (bone marrow activity: β = 0.20, p = 0.01) and subclinical CVD (VI: β = 0.31, p < 0.001; NCB: β = 0.27, p < 0.001) The AmygA-CVD association was in part mediated by HMPA (VI: 20.9%, NCB: 36.7%). Following 1 year of PSO treatment in those with severe disease, improvement in skin disease was accompanied by a reduction in AmygA, bone marrow activity, and VI, with no progression of NCB.
CONCLUSIONS: In PSO, a chronic inflammatory disease state, AmygA, which is a manifestation of chronic stress, substantially contributes to the risk of subclinical CVD. Additional studies that use psychometric measures of stress are required to explore therapeutic impact.
引用
- Goyal A, Dey AK, Chaturvedi A, et al. Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study. JACC Cardiovasc Imaging. 2018. PMID: 30448131. doi:10.1016/j.jcmg.2018.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。